FDA Brief

Warning letters Drugs

FDA warning letter to

Sichuan Deebio Pharmaceutical Co. Ltd.

Issued Feb 5, 2024Posted Feb 20, 2024Center for Drug Evaluation and Research | CDER

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.